sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Pen Needles Market Size & Forecast

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 2.53 Billion
Market Size 2025 · Base Year
US$ 4.82 Billion
Projected Market Size by 2033
8.39%
CAGR · 2026–2033
SHARE
BMIPUB00036952 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including BD, Novo Nordisk, Ypsomed, Terumo Corporation, Owen Mumford
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Growing Diabetes Prevalence Drives Insulin Pen Adoption

  • Rising Obesity Rates Increase Demand for Injectable Therapies

  • Increasing Home Based Diabetes Management Drives Demand

Where Growth Opportunities Exist

Key Opportunities

  • Growing Demand for Safer Needle Technologies Worldwide

  • Expanding GLP 1 Drug Use Broadens Pen Needle Demand

  • Rising Home Healthcare Adoption Expands Market Potential

What Could Slow It Down

Market Restraints

  • Needle Phobia Limits Patient Acceptance of Injections

  • Improper Needle Disposal Creates Environmental Concerns

  • High Cost of Specialty Pen Needles Limits Adoption

Market Segmentation

Coverage by Segment

Product Type

Standard Pen Needles
Safety Pen Needles

Drug Type

Insulin
GLP-1
Growth Hormone

Disease Indication

Diabetes
Obesity
Hormone Deficiency

Needle Size

4 mm
5 mm
6 mm
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

BD
Novo Nordisk
Ypsomed
Terumo Corporation
Owen Mumford
HTL-Strefa
B. Braun
UltiMed
Nipro
Dongbao Pen Needles
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 2.53 Billion
Market Size 2033 US$ 4.82 Billion
CAGR 2026–2033 8.39%
Segments By Product Type (Standard Pen Needles, Safety Pen Needles)  |  By Drug Type (Insulin, GLP-1, Growth Hormone)  |  By Disease Indication (Diabetes, Obesity, Hormone Deficiency)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00036952
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Pen Needles Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.